Arcturus Therapeutics Holdings (ARCT) Total Current Liabilities (2018 - 2026)

Arcturus Therapeutics Holdings has reported Total Current Liabilities for 9 years, with the latest figure at $34.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 30.44% year-over-year to $34.4 million; the trailing twelve-month figure through Mar 2026 stood at $34.4 million (down 30.44% YoY), and the FY2025 full-year result was $36.4 million, down 44.45% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $34.4 million, down from $36.4 million in the prior quarter.
• The five-year high for Total Current Liabilities was $127.0 million in Q4 2022, with the low at $31.7 million in Q3 2025.
• Historically, Total Current Liabilities has averaged $76.1 million across 5 years, with a median of $82.0 million in 2023.
• Annual changes were most pronounced in 2022 — Total Current Liabilities soared 101.2% — and 2025, when it slumped 57.2%.
• Arcturus Therapeutics Holdings' Total Current Liabilities stood at $127.0 million in 2022, then sank by 35.43% to $82.0 million in 2023, then slipped by 20.12% to $65.5 million in 2024, then plunged by 44.45% to $36.4 million in 2025, then fell by 5.53% to $34.4 million in 2026.
• The last three Total Current Liabilities figures came in at $34.4 million (Q1 2026), $36.4 million (Q4 2025), and $31.7 million (Q3 2025), per Business Quant data.